INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2009

Cyanobacterial BMAA bioaccumulates in food chains and is detected in brains of patients with ALS, Alzheimer's disease, and Guamanian ALS/PDC.

This review discusses the hypothesis that the neurotoxin beta-methylamino-L-alanine (BMAA), produced by cyanobacteria, may contribute to ALS and other neurodegenerative diseases. Protein-bound BMAA was identified in brains of Guamanians dying of ALS/PDC (average 627 microg/g, 5 mM) and North American Alzheimer's disease patients (average 95 microg/g, 0.8 mM), but not in controls. Although Montine et al. failed to replicate these findings using different methods, subsequent work confirmed protein-bound BMAA (>100 microg/g) in brains of North American patients dying with ALS and Alzheimer's disease.

Shows an association, not proof of cause and effect.

Study type
Narrative review / hypothesis paper
Who was studied
Human brain tissues (Guam ALS/PDC cases, North American ALS and AD patients, controls)
What was measured
Detection of BMAA in brain tissues and food chain

THE PAPER

Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.

Bradley WG, Mash DC. Amyotroph Lateral Scler, 2009.

PubMed 19929726 ↗DOI 10.3109/17482960903286009 ↗

Brain & moodFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.